Activating Transcription Factor 6 (NT) Blocking Peptide
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Product Concentration 0.2 mg/ml Amino Acid Location 17 amino acids near the amino terminus of human ATF6. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Amino Acid Sequence 17 amino acids near the amino terminus of human ATF6. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground Activating Transcription Factor 6 peptide is applicable as a control peptide for blocking antibody binding in Western blotting. References & Citations1. Dahl CA, Schall RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992; 148:597-603.
2. Kim S-H, Han S-Y, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF-a. Immunity 2005; 22:131-42.
3. Cagnard N, Letourneur F, Essabbani A, et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cyto. Network 2005; 16:289-92. |
Related Products
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
